P N. Tonin
Affiliations: | McGill University, Montreal, QC, Canada |
Area:
Genetics, Molecular Biology, OncologyGoogle:
"P Tonin"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Alenezi WM, Fierheller CT, Serruya C, et al. (2023) Genetic analyses of DNA repair pathway associated genes implicate new candidate cancer predisposing genes in ancestrally defined ovarian cancer cases. Frontiers in Oncology. 13: 1111191 |
| Fierheller CT, Alenezi WM, Serruya C, et al. (2023) Molecular Genetic Characteristics of , a Proposed New Ovarian Cancer Predisposing Gene. Genes. 14 |
| Fierheller CT, Guitton-Sert L, Alenezi WM, et al. (2021) A functionally impaired missense variant identified in French Canadian families implicates FANCI as a candidate ovarian cancer-predisposing gene. Genome Medicine. 13: 186 |
| Matis TS, Zayed N, Labraki B, et al. (2021) Current gene panels account for nearly all homologous recombination repair-associated multiple-case breast cancer families. Npj Breast Cancer. 7: 109 |
| Fierheller CT, Alenezi WM, Tonin PN. (2021) The Genetic Analyses of French Canadians of Quebec Facilitate the Characterization of New Cancer Predisposing Genes Implicated in Hereditary Breast and/or Ovarian Cancer Syndrome Families. Cancers. 13 |
| Amuzu S, Carmona E, Mes-Masson AM, et al. (2021) Candidate Markers of Olaparib Response from Genomic Data Analyses of Human Cancer Cell Lines. Cancers. 13 |
| Elkholi IE, Di Iorio M, Fahiminiya S, et al. (2021) Investigating the causal role of MRE11A p.E506* in breast and ovarian cancer. Scientific Reports. 11: 2409 |
| Felicio PS, Grasel RS, Campacci N, et al. (2020) Whole-exome sequencing of non-BRCA1/BRCA2 mutation carrier cases at high-risk for hereditary breast/ovarian cancer. Human Mutation |
| Le Page C, Amuzu S, Rahimi K, et al. (2020) LESSONS LEARNED FROM UNDERSTANDING CHEMOTHERAPY RESISTANCE IN EPITHELIAL TUBO-OVARIAN CARCINOMA FROM BRCA1 AND BRCA2 MUTATION CARRIERS. Seminars in Cancer Biology |
| Alenezi WM, Fierheller CT, Recio N, et al. (2020) Literature Review of BARD1 as a Cancer Predisposing Gene with a Focus on Breast and Ovarian Cancers. Genes. 11: 856 |